Wechselwirkungen · Firdapse (previously Zenas)
FIRDAPSE 10 mg tablets · Abschnitt 4.5 · PDF-Seite 4
HOS-210237 · Präparat HOS-154477
Medicinal products eliminated through metabolism or active secretion There are no data on the effects of amifampridine on the metabolism or active secretion of other medicinal products. Thus, special care should be taken in patients undergoing concomitant treatment with medicinal products eliminated through metabolism or active secretion. Monitoring is advised when possible. The dose of the concomitantly given medicinal product should be adjusted if necessary. Concomitant use of medicinal products with a narrow therapeutic window is contraindicated (see section 4.3).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-05-25T11:00:00Z · SHA-256 92cbbf47b9125cbf72b4c63d78ca50f05a820bbcbe9f450c757171186f057752 · Passage ffc4c07faf51bfdf2c66fa10e9c836683663d006fbb230223af4fac0e7575a63 · Zeichen 30–603 im Abschnitt